Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Beximco Pharmaceuticals Limited
BXPCurrent price
21.5 GBX
0 GBX (0.00%)
Last closed
21.5 GBX
Company
www.beximcopharma.com
ISIN
unknown
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
London Exchange
Capitalization
95 338 723 GBX
Yield for 12 month
-44.16 %
1Y
3Y
5Y
10Y
15Y
BXP
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. Address: 19 Dhanmondi R/A, Dhaka, Bangladesh, 1205
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11 146.28 GBXP/E ratio
2.6875Dividend Yield
11.7 %Current Year
+24 734 470 771 GBX
Last Year
+21 838 464 815 GBX
Current Quarter
+6 921 036 196 GBX
Last Quarter
+6 868 673 610 GBX
Current Year
+10 905 869 336 GBX
Last Year
+9 961 558 713 GBX
Current Quarter
+3 025 617 983 GBX
Last Quarter
+3 081 327 239 GBX
Key Figures BXP
1 year
3 years
5 years
10 years
EBITDA
9 381 449 085 GBX
Operating Margin TTM
PE Ratio
2.6875
Return On Assets TTM
6.97 %
PEG Ratio
–
Return On Equity TTM
10.99 %
Wall Street Target Price
11 146.28 GBX
Revenue TTM
42 826 162 599 GBX
Book Value
103.54 GBX
Revenue Per Share TTM
Dividend Share
3.48 GBX
Quarterly Revenue Growth YOY
15 %
Dividend Yield
11.7 %
Gross Profit TTM
15 619 756 428 GBX
Earnings per share
0.08 GBX
Diluted Eps TTM
0.08 GBX
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
43.5 %
Profit Margin
12.37 %
Dividend Analytics BXP
Dividend growth over 5 years
45 %Continuous growth
–Payout Ratio 5 years average
39 %Dividend History BXP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.03
Ex Dividend Date
10.11.2023
Forward Annual Dividend Yield
11.7 %
Last Split Factor
110:100
Payout Ratio
0.45 %
Last Split Date
23.11.2020
Dividend Date
–
Stock Valuation BXP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
2.6875
Forward PE
4.583
Enterprise Value Revenue
0.9329
Price Sales TTM
0.0022
Enterprise Value EBITDA
4.9874
Price Book MRQ
0.3285
Financials BXP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BXP
For 52 weeks
19.21 GBX
44.73 GBX
50 Day MA
32.69 GBX
Shares Short Prior Month
–
200 Day MA
37.24 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart